BetterLife Pharma (BETRF) Other financing activities (2018 - 2026)
BetterLife Pharma (BETRF) posted quarterly Other financing activities of $186067.1 for Q2 2026, up 959.11% year-over-year from $17568.2 in Q2 2025, and up 959.11% quarter-over-quarter from $17568.2 in Q2 2025.
BetterLife Pharma (BETRF) Other financing activities (2018 - 2026) Analysis & Trends
BetterLife Pharma's Other financing activities history runs 9 years deep, the most recent figure standing at $186067.1 for Q2 2026.
- In Q2 2026, Other financing activities rose 959.11% year-over-year to $186067.1; the TTM figure through Apr 2026 stood at -$1427.6 billion (down 27999.15% YoY), while the FY2023 annual figure was $56627.0, changed N/A from the prior year.
- Other financing activities for Q2 2026 stood at $186067.1, up from $17568.2 in the prior quarter.
- The five-year high for Other financing activities was $1732.8 billion in Q4 2022, with the low at -$1706.4 billion in Q1 2023.
- The 5-year median for Other financing activities is $191628.8 (2026), against an average of $1.3 billion.
- The sharpest annual moves came in 2023 and 2024: Other financing activities soared 597467549.31% in 2023, then tumbled 1382629342.5% in 2024.
- BetterLife Pharma's Other financing activities stood at $1732.8 billion in 2022, then sank by 100.0% to $103249.1 in 2023, then tumbled by 1382629342.5% to -$1427.6 billion in 2024, then jumped by 100.0% to $17568.2 in 2025, then soared by 959.11% to $186067.1 in 2026.
- Business Quant data shows BETRF's Other financing activities at $186067.1 in Q2 2026, $17568.2 in Q2 2025, and -$1427.6 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 186,067.08 |
| Apr 30, 2026 | 186,067.08 |
| Apr 30, 2025 | 17,568.22 |
| Apr 30, 2025 | 17,568.22 |
| Oct 31, 2024 | -1,427.55 Bn |
| Oct 31, 2024 | -1,427.55 Bn |
| Jul 31, 2024 | 514.87 Bn |
| Jul 31, 2024 | 514.87 Bn |
| Apr 30, 2024 | 917.80 Bn |
| Apr 30, 2024 | 917.80 Bn |
| Oct 31, 2023 | 103,249.14 |
| Oct 31, 2023 | 103,249.14 |
| Jul 31, 2023 | -1,194.34 Bn |
| Jul 31, 2023 | -1,194.34 Bn |
| Apr 30, 2023 | 1,178.15 Bn |
| Apr 30, 2023 | 1,178.15 Bn |
| Jan 31, 2023 | -1,706.35 Bn |
| Jan 31, 2023 | -1,706.35 Bn |
| Oct 31, 2022 | 1,732.82 Bn |
| Oct 31, 2022 | 1,732.82 Bn |